A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis

被引:90
作者
Bernier, SG
Lazarus, DD
Clark, E
Doyle, B
Labenski, MT
Thompson, CD
Westlin, WF
Hannig, G
机构
[1] Praecis Pharmaceut Inc, Dept Preclin Res, Waltham, MA 02451 USA
[2] Praecis Pharmaceut Inc, Dept Analyt Pharmacol, Waltham, MA 02451 USA
关键词
D O I
10.1073/pnas.0404105101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The hallmark of rheumatoid arthritis (RA) is the progressive destruction of articular joints, characterized by invasive synovial hyperplasia and pathological neovascularization. Here we report that PPI-2458, a member of the fumagillin class of irreversible methionine aminopeptidase-2 (MetAP-2) inhibitors, potently inhibits the proliferation of human fibroblast-like synoviocytes (HFLS-RA), derived from RA patients, with a growth inhibitory concentration 50 (GI(50)) of 0.04 nM and a maximum inhibition of >95% at 1 nM. Human umbilical vein endothelial cells (HUVEC) are similarly inhibited in proliferation by PPI-2458 (GI(50), 0.2 nM). We developed a method to measure the level of MetAP-2 enzyme inhibition after exposure to PPI-2458 and demonstrate that growth inhibition of PPI-2458-sensitive HFLS-RA and HUVEC is linked to MetAP-2 enzyme inhibition, in a dose-dependent fashion. The secretion of several inflammatory mediators such as IL-6 and vascular endothelial growth factor from activated HFLS-RA was not inhibited by PPI-2458. The CNS toxicity profile of PPI-2458, determined by the incidence of seizures, is significantly improved over that of the parental compound TNP-470. In the rat model of peptidoglycan-polysaccharide-induced arthritis, PPI-2458 significantly attenuated paw swelling when therapeutically administered after the onset of chronic disease. We suggest that the mechanism of PPI-2458 action, highly selective and potent antiproliferative activity on HFLS-RA and HUVEC in vitro, a significantly improved CNS toxicity profile, and marked attenuation of chronic disease in the rat peptidoglycan-polysaccharide arthritis model in vivo, positions this compound as a drug for the treatment of RA.
引用
收藏
页码:10768 / 10773
页数:6
相关论文
共 42 条
[1]  
ABE J, 1994, CANCER RES, V54, P3407
[2]  
Bhargava P, 1999, CLIN CANCER RES, V5, P1989
[3]  
CHANG YH, 1992, J BIOL CHEM, V267, P8007
[4]   The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae [J].
Chen, SP ;
Vetro, JA ;
Chang, YH .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 398 (01) :87-93
[5]   Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies [J].
Chicheportiche, Y ;
Chicheportiche, R ;
Sizing, I ;
Thompson, J ;
Benjamin, CB ;
Ambrose, C ;
Dayer, JM .
ARTHRITIS RESEARCH, 2002, 4 (02) :126-133
[6]   Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis. [J].
Choy, EHS ;
Panayi, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :907-916
[7]   Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium [J].
Clausen, BE ;
Bridges, SL ;
Lavelle, JC ;
Fowler, PG ;
Gay, S ;
Koopman, WJ ;
Schroeder, HW .
MOLECULAR MEDICINE, 1998, 4 (04) :240-257
[8]   P21 CIP1 controls proliferating cell nuclear antigen level in adult cardiomyocytes [J].
Engel, FB ;
Hauck, L ;
Boehm, M ;
Nabel, EG ;
Dietz, R ;
von Harsdorf, R .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (02) :555-565
[9]   Evolving concepts of rheumatoid arthritis [J].
Firestein, GS .
NATURE, 2003, 423 (6937) :356-361
[10]   How important are T cells in chronic rheumatoid synovitis? II. T cell-independent mechanisms from beginning to end [J].
Firestein, GS ;
Zvaifler, NJ .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :298-308